Clinical studies have since associated HbC and α+thalassemia with malaria protection (Williams, 2006, Taylor et al., 2012), and shown that α+thalassemia antagonizes HbAS; that is, HbAS children who co-inherit α+thalassemia are not protected from malaria (Williams et al., 2005). Here, KRT88P is linked to malaria.